[ad_1]
Scientists in Glasgow undertake a pioneering cancer study after receiving £ 1.8 million in funding.
Researchers at the Beatson Institute of Cancer Research UK will receive this sum over the next five years as part of a £ 19 million investment in a global project to determine why some cancers are specific to certain tissues.
The team fought against international competition for funding for the charity's Grand Challenge Awards.
Professor Owen Sansom, director of the institute, said, "My team is trying to understand for several years why mutations of a gene called APC are really common in bowel cancer.
"With this funding, we will try to understand why we only see the APC mutation in bowel cancer; why not bad cancer or skin cancer?
"If we can determine why this mutation of the gene does not cause cancer in these other organs, we hope to find a way to make the bowel resistant to the mutation of APC and other organs. to prevent cancer from developing. "
Dr. Victoria Steven, spokesperson of Cancer Research UK for Scotland, said: "The Grand Challenge offers us the perfect opportunity to tackle complex issues and cross new frontiers in our understanding of cancer, to transform the lives of patients.
"Scots have every right to feel proud of the world-clbad research that is on their doorstep and their fundraising efforts that help defeat cancer."
Source link
